Company Name:Repligen Corporation
CEO: Tony J. Hunt

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.


Key numbers

Market Capitalization:4407827063
Shares Outstanding: 52058900
Float: 47278487.389699996
Next Earning Date:2020-02-20
TTm EPS: 0.5188
TTm Dividend Rate:
200 days moving average:74.42
50 days moving average: 79.4
One day percent Change: 6.96



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,